The Government Stopped Checking Whether Insurers Follow the Parity Law. It Just Said, Carefully, That It's Watching Again.
A year after suspending enforcement, the Department of Labor issued an interim roadmap for policing how insurers limit mental health and addiction coverage.
If an insurer has ever made you fight for a prior authorization on residential treatment, or bounced you between three case managers before approving a therapy referral, this week’s news is about the rule that’s supposed to stop exactly that — and about how long it’s been unenforced.
The Department of Labor’s Employee Benefits Security Administration suspended active enforcement of the Mental Health Parity and Addiction Equity Act’s toughest provision in 2025. On September 8, Assistant Secretary Daniel Aronowitz issued a bulletin describing an interim roadmap for re-enforcing it: the requirement that health plans document, through formal comparative analyses, that “nonquantitative treatment limitations” — prior authorization, medical necessity criteria, provider-network adequacy standards, the everyday administrative friction of getting care approved — aren’t applied more restrictively to mental health and substance use disorder benefits than to physical health benefits.
Aronowitz’s own framing of the pause matters as much as the bulletin itself: the agency, he said, had heard that its prior enforcement approach “created substantial confusion and unnecessary burdens on health plans” — language that reads, to a provider who’s been navigating a denial backlog for a year, less like a fix than like an explanation for why the fix was delayed. The bulletin is explicitly interim, covering where EBSA plans to focus in the meantime — the everyday NQTLs listed above — while a fuller rulemaking revising the MHPAEA regulations is still expected before the end of 2026. Nothing about the underlying law changed. What changed is whether anyone at the federal level was checking whether insurers followed it, and for roughly a year, the honest answer was: not actively.
For a treatment provider or case manager, the useful move this week isn’t waiting on the final rule — it’s starting to log every NQTL-shaped denial now: every prior-authorization delay, every “not medically necessary” reversal, every network gap that took weeks to route around. A comparative-analysis requirement that isn’t actively enforced still creates a paper trail an enforced version can use once EBSA’s roadmap turns into actual audits. Insurers know an enforcement pause when they see one; so should the people documenting what happened during it.
If you’ve spent the past year getting bounced between denials and appeals for coverage that was supposed to be guaranteed by law, this bulletin doesn’t undo that year. It’s the government admitting, in bureaucratic language, that the year happened. The provisions didn’t disappear during the pause. The willingness to check them did — and this bulletin is the government saying, carefully, that the checking is coming back.
Sources Cited
- 01.CTrump Administration Issues Interim Enforcement Roadmap for Mental Health Parity LawBehavioral Health Business
- 02.CTrump Administration Issues Interim Enforcement Roadmap for Mental Health Parity Law (mirror)Behavioral Healthcare Network
Filed Under
policytreatment
Keep up with the reporting.
One email each morning with the stories that put days like this in context.
Continue reading
More from this section
The Federal Government Is Deciding Kratom's Fate Today. 32,000 People Already Told It What They Think.
The federal comment period on scheduling concentrated 7-hydroxymitragynine (7-OH), the potent kratom derivative, closes today with over 32,000 comments filed — as Pennsylvania and North Dakota fight the same battle at the state level.
Policy & FundingThe House Majority Leader Called Cannabis a 'Gateway Drug.' The Federal Data Out the Same Week Told a Different Story.
A new GAO report on cannabis banking landed the same week House Majority Leader Steve Scalise called marijuana a 'gateway drug' — while a NORML read of FBI data shows it's still driving over half of drug arrests in some states.
Policy & FundingThe Money Was Supposed to Bury Fewer People. A New Jersey Town Spent It on Cameras That Watch License Plates.
Washington Township, New Jersey spent nearly $60,000 in opioid settlement money on license-plate-reader cameras — one of at least 19 police agencies nationwide doing the same. The pattern echoes the 1998 tobacco settlement almost exactly.